Assessment of DHA On Reducing Early Preterm Birth

• Status: Completed
• Trial end date: 2020-10-05
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine if giving a larger amount of DHA than currently included in some prenatal supplements can reduce early preterm birth (birth before 34 weeks of pregnancy).

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Kansas Medical Center
• Collaborators: Nationwide Children's Hospital; Ohio State University; University of Cincinnati

Criteria

Inclusion Criteria:

• Pregnant females 18 years and older 12 to 20 weeks gestation at study entry

• Agree to consume study capsules and a typical prenatal supplement of 200 mg DHA

• Available by telephone

• Able to speak and read in either English or Spanish language

Exclusion Criteria:

• Expecting multiple infants

• Gestational age at baseline <12 weeks or >20 weeks

• Unable or unwilling to agree to consume capsules until delivery

• Unwilling to discontinue use of another prenatal supplement that contains greater than or equal to 200 mg DHA per day

• Women with allergy to any component of DHA product (including algae), soybean oil or corn oil